跳至主要内容
临床试验/NCT07048626
NCT07048626进行中(未招募)不适用

Impact of Low-Level Laser Therapy on Hair Regrowth Post PRP Treatment

Superior University2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2025年3月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
22
试验地点
2
主要终点
Physician's Global Assessment (PGA) scale

研究概览

简要总结

Low-level laser stimulates cells in the hair follicles, which promotes hair growth. The patient's own blood platelets are used in platelet-rich plasma treatment to encourage hair growth. Combining low-level laser treatment with platelet-rich plasma will promote hair growth in patients.

详细描述

To determine the impact of low-level laser therapy on hair regrowth following prp treatment.

This will be case control study conducted on 22 participants with androgenetic alopecia (AGA).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adults between 18-35 years diagnosed with androgenic alopecia or other non-scarring hair loss conditions.
  • •Having the Norwood-Hamilton scale placed in stages I-V for men Ludwig scale in stages I-III for women .

排除标准

  • •Use of systemic medications (e.g., corticosteroids, immunosuppressants) or treatments affecting hair regrowth within the last 3 months.
  • •History of hypersensitivity or adverse reactions to laser therapy
  • •Active systemic diseases such as uncontrolled diabetes, autoimmune disorders, or malignancies
  • •Pregnant or breastfeeding individuals.
  • •Patients with pacemakers or implanted medical devices contraindicated with low level laser therapy.
  • •History of hair transplant surgery in the treatment area

研究组 & 干预措施

low leve laser therapy post prp treatment

Active Comparator

干预措施: low level laser therapy post prp treatment (Combination Product)

PRP treatment

Experimental

干预措施: PRP treatment (Combination Product)

结局指标

主要结局

Physician's Global Assessment (PGA) scale

时间窗: 12 Months

The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Muhammad Naveed Babur

Principal Investigator

Superior University

研究点 (2)

Loading locations...

相似试验